NCT05428605View on ClinicalTrials.gov

In Vitro Immunomodulation in Membranous Nephropathy Relapses

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

November 23, 2024

Study Completion Date

December 31, 2024

Conditions
Extramembranous Glomerulopathy
Interventions
OTHER

Blood sample

10 mL on lithium heparinate tubes, 10 mL on EDTA tubes.

Trial Locations (1)

06200

RECRUITING

Centre Hospitalier Universitaire de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER